SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, TGI, AVAV, NARI on Behalf of ShareholdersNEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AXL, TGI, AVAV on Behalf of ShareholdersNEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Triumph Group, Inc. (NYSE – TGI), AeroVironment, Inc. (Nasdaq – AVAV), Paragon 28, Inc. (NYSE - FNA), American Axle & Manufacturing (NYSE - AXL)BALA CYNWYD, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc. (
NYSEFNA) to Zimmer Biomet Holdings, Inc.
NYSE: ZBHNYSEZBH)
FNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paragon 28, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Paragon 28, Inc. (
NYSEFNA) to Zimmer Biomet Holdings, Inc. for $13.00 per share in cash is fair to Paragon 28 shareholders. Paragon 28 shareholders will also receive a non-tradeable contingent value right entitling the holder to receive up to $1.00 per share in cash if certain revenue milestones are achieved.
Paragon 28 Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024
Paragon 28, Inc. (
NYSEFNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited net revenue for the fourth quarter and full year ended December 31, 2024.
Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Paragon 28, Inc. (
NYSEFNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.
Paragon 28 Appoints Dave Demski to Board of Directors
Paragon 28, Inc. (
NYSEFNA), (the “Company”) a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities.
FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. (“Paragon 28” or “the Company”) (
NYSEFNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
FNA Investors Have Opportunity to Lead Paragon 28, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paragon 28, Inc. (“Paragon 28” or “the Company”) (
NYSEFNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
SHAREHOLDER REMINDER: Berger Montague Reminds Paragon 28 (NYSE: FNA) Investors of the November 29, 2024 DeadlinePHILADELPHIA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”).
PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paragon 28, Inc. and Encourages Investors to Contact the FirmNEW YORK, Nov. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
DEADLINE NEXT WEEK: Berger Montague Advises Paragon 28 (NYSE: FNA) Investors to Contact the Firm Before November 29, 2024PHILADELPHIA, Nov. 23, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”).
Faruqi & Faruqi Reminds Paragon 28 Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 29, 2024 - FNAFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options
PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paragon 28, Inc. and Encourages Investors to Contact the FirmNEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Paragon 28Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options
Paragon 28 to Present at the 36th Annual Piper Sandler Healthcare Conference
Paragon 28, Inc. (
NYSEFNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO, and Chadi Chahine, CFO, will participate in a fireside chat at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3, 2024, at 8:30 a.m. Eastern Time / 6:30 a.m. Mountain Time.
Paragon 28 Reports Third Quarter 2024 Financial Results and Raises 2024 Net Revenue Guidance
Paragon 28, Inc. (
NYSEFNA) (“Paragon 28” or "Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today reported financial results for the quarter ended September 30, 2024 and raised its 2024 net revenue guidance.
PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paragon 28, Inc. and Encourages Investors to Contact the FirmNEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
FNA INVESTOR ALERT: Kirby McInerney LLP Notifies Paragon 28, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitNEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the November 29, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) securities during the period of May 5, 2023 through August 8, 2024, inclusive (“the Class Period”).
PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Paragon 28, Inc. and Encourages Investors to Contact the FirmNEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (
NYSEFNA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Paragon 28 common stock between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”). Investors have until November 29, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
